Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole in Postmenopausal Hormone Receptor Positive Breast Cancer (PreFace)
NCT01908556Phase 4Unknown
- Sponsor
- Institut Frauengesundheit
- Start
- Feb 2009
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of letrozole in breast cancer, sponsored by Institut Frauengesundheit. Status: unknown.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01908556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908556.